The server encountered an error and could not complete your request. If the problem persists, please contact us using the ...

Novo Nordisk continues to deliver double-digit revenue and profit growth, driven by both its diabetes and obesity drug franchises. Learn more on NVO stock here.

Novo Nordisk A/S (NYSE:NVO) is one of the top NYSE stocks with the highest upside potential. On August 5, UBS downgraded Novo Nordisk A/S (NYSE:NVO) to Neutral from Buy, bringing the price target ...

The pioneering Danish drugmaker was once the most valuable company in Europe, but analysts say a number of missteps reversed its fortunes.

Novo Nordisk(NYSE: NVO) stock imitated the company's leading product on Wednesday by slimming down in price. The Danish pharmaceutical's shares lost nearly 4% of their value following its latest ...

Although Novo Nordisk continues to post double-digit increases thanks largely to Wegovy and Ozempic, it has been in the investor doghouse so far this month.

The Minnesota Supreme Court ruled Wednesday that it is legal for Minnesotans to possess ghost guns without a serial number because current state law does not clearly restrict it.

Novo Nordisk A/S NVO reported second-quarter 2025 earnings of 97 cents per American Depositary Receipt (ADR), which beat the Zacks Consensus Estimate of 93 cents. The company had reported earnings ...

Stock futures were rising again on the eve of another tariff deadline as investors juggled strong earnings with more signs of U.S. economic weakness. Shares closed in the red Tuesday after the ISM ...

The Motley Fool recommends Novo Nordisk. The Motley Fool has a disclosure policy. Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services.

Novo Nordisk said sales of its blockbuster Wegovy weight-loss drug soared last quarter. (Hollie Adams/Reuters) ↘️ Novo Nordisk (NVO): The pharmaceutical company's quarterly sales of its ...